Introduction
Many G-protein-coupled receptors regulate growth and differentiation of selected cell types by activating the mitogen-activated protein kinase (MAPK) cascade [1, 2] . Different G-protein subunits and a variety of intracellular pathways appear to be involved in these responses [1] [2] [3] . The ability of the ␣ chains of the pertussis toxin-sensitive G i/o proteins to activate MAPK is well documented. Studies expressing activated mutants have demonstrated that G ␣ i2 induces MAPK activation in Rat-1 fibroblasts [4] and G ␣ o enhances growth factor-dependent stimulation of MAPK in Chinese hamster ovary (CHO) cells [5] . In addition, the use of pertussis toxin-insensitive or dominant negative mutants of G ␣ o has shown that this subunit mediates the MAPK response to muscarinic M 1 receptors and opioid receptors in CHO and neuroblastoma ! glioma NG108-15 cells, respectively [6, 7] . The mechanisms used by G ␣ i2 and G ␣ o to activate MAPK remain only partially understood [2, 5, 6] . There is evidence that G ␣ i/o control the function of the small G protein Rap1 by interacting with the GAP protein Rap1GAPII [8] [9] [10] . Two different models of Rap1GAPII regulation by G ␣ i/o have been proposed. Studies investigating the action of G ␣ o have shown that the inactive form of this subunit binds to Rap1GAPII and prevents the action of the GAP protein on Rap1. Activation of G ␣ o would then lead to release of Rap1GAPII and termination of the Rap1 signal [8] . Some results indicate that G ␣ i2 regulates Rap1GAPII by a similar mechanism [10] . However, other studies have demonstrated that the active, and not the inactive, form of G ␣ i2 interacts with Rap1GAPII. This in turn would result in Rap1 inactivation [9] . Recent data suggest that Rap1 regulation by G i/o ␣ chains is probably even more complex because, at least in the case of G ␣ o , interaction with Rap1GAPII also targets the GAP protein for proteasomal degradation [10] .
The role of Rap1 in regulation of the MAPK pathway is controversial. There have been several suggestions that Rap1 can inhibit the MAPK cascade by acting as an antagonist of Ras [11] [12] [13] . Rap1 has also been shown to stimulate MAPK via activation of the B-Raf kinase in neurons and other cell systems [13] [14] [15] . However, other studies have failed to detect any significant effect of Rap1 on MAPK in various cell types [12, 16, 17] . The ability of Rap1 to inhibit the MAPK cascade has suggested that G i/o ␣ chains stimulate MAPK via Rap1GAPII-mediated inactivation of Rap1. Indeed, in 293T cells the MAPK response to the G i -coupled muscarinic M 2 receptor is enhanced by expression of Rap1GAPII and inhibited by a Rap1GAPII dominant negative mutant [9] . Whether stimulation of the MAPK cascade by G ␣ o involves regulation of Rap1 has not been investigated yet.
We have previously shown that activated G ␣ o strongly potentiates the MAPK response to the epidermal growth factor (EGF) receptor in CHO cells [5] . Here we report that in the same cell system, expression of wild-type G ␣ o does not modify the levels of activated Rap1. In contrast, the constitutively active mutant G ␣ o -Q205L potently inhibits the activation of Rap1 induced by EGF. Our results demonstrate that Rap1 inhibition does not mediate the stimulatory action of G ␣ o on MAPK and indicate the existence of Rap1-independent pathway(s) connecting this G-protein subunit to the MAPK cascade.
Materials and Methods

Materials
The G ␣ o antiserum used for immunoblot analysis was generated by immunization of rabbits with a synthetic peptide corresponding to the C-terminal sequence ANNLRGCGLY. The anti-HA mouse monoclonal antibody 12CA5 was from Boehringer Mannheim (Mannhein, Germany); the anti-phospho-p44/42 MAPK (Thr202/Tyr204) rabbit polyclonal antibody was from New England BioLabs (Beverly, Mass., USA); the mouse monoclonal antibody against Rap1 was from Transduction Laboratories (Lexington, Ky., USA); the anti-G ␣ o mouse monoclonal antibody used for immunocytochemistry and anti-Rap1 rabbit polyclonal antibodies were from Santa Cruz Biotechnology (Santa Cruz, Calif., USA). Glutathione-Sepharose 4B and protein A-Sepharose CL-4B were purchased from Amersham Pharmacia Biotech (Uppsala, Sweden). Isopropyl ␤ -D -1-thiogalactopyranoside and polyornithine were from Sigma (St. Louis, Mo., USA), human EGF was from Boehringer Mannheim and human fibroblast growth factor (FGF) was from Calbiochem (La Jolla, Calif., USA). All other chemicals were reagent grade.
DNA Constructs
The cDNAs encoding wild-type G ␣ o and the activated mutant G ␣ o -Q205L, the human EGF receptor and HA-p44 MAPK were as previously described [5] . The plasmid for bacterial expression of a GST fusion protein of the Rap1-binding domain of Ral GDP dissociation stimulator (RalGDS-RBD) and pMT2-HA vectors containing the coding sequences of Rap1GAPII, wild-type Rap1A and the activated mutant Rap1A-G12V were kindly provided by J.L. Bos (University of Utrecht, The Netherlands).
Cell Culture, Transfections and Immunoblot Analysis of Protein Expression
CHO cells were maintained in culture in Dulbecco's modified Eagle's medium-Ham's F12 (1: 1) supplemented with 10% FCS. Transient transfections were performed using the Transfectam reagent (Promega, Madison, Wisc., USA) as previously described [5] . The total amount of transfected DNA was kept constant by addition of empty vector. Cells were then incubated for 24 h in 10% FCS medium and serum starved for 18 h in medium containing 0.5% FCS. The expression of HA-tagged proteins was assessed by immunoblot analysis of cell lysates with anti-HA antibodies. Proteins were separated by 12% (for HA-Rap1) or 10% (for HAp44 MAPK and HA-Rap1GAPII) SDS-PAGE and transferred to nitrocellulose filters (Schleicher & Schuell, Keene, N.H., USA). Filters were blocked for 1 h in Blotto (50 m M Tris-HCl, pH 7.4, 150 m M NaCl, 0.05% Tween-20, 0.01% sodium azide, and 5% nonfat dry milk), incubated for 2 h at room temperature in Blotto containing 2.5 g/ml anti-HA antibodies, incubated for 2 h in Blotto with horseradish peroxidase-conjugated secondary antibodies (Bio-Rad, Hercules, Calif., USA) and finally processed for enhanced chemiluminescence (Amersham Pharmacia Biotech). For immunoblot analysis of G ␣ o expression, lysates were subjected to 10% SDS-PAGE and filters were incubated with G ␣ o antiserum (1: 3,000) overnight at 4 ° C in Blotto. Detection was performed as described above.
Rap1 Activation Assay
Activation of Rap1 was measured using the specific probe Ral-GDS-RBD [18] . The GST fusion protein of RalGDS-RBD was ex- aprotinin and 10 g/ml leupeptin. After sonication and incubation with 1% Triton X-100 for 40 min at 4 ° C, lysates were clarified by centrifugation at 13,000 rpm for 10 min at 4 ° C. GST-RalGDS-RBD was immobilized by incubating lysates for 1 h at 4 ° C with glutathione-Sepharose beads pre-equilibrated in PBS containing 1 m M EDTA, 0.5 m M DTT, 1% Triton X-100, 10% glycerol, 0.1 m M Na 3 VO 4 , 1 m M PMSF, 1 g/ml aprotinin and 1 g/ml leupeptin. Beads were washed three times with the same buffer and three times with Ral buffer (50 m M Tris-HCl, pH 7.5, 200 m M NaCl, 2.5 m M MgCl 2 , 1 m M DTT, 1% Nonidet P-40, 10% glycerol, 1 m M Na 3 VO 4 , 10 m M NaF, 250 M PMSF, 10 g/ml aprotinin and 10 g/ml leupeptin). Immobilized GST-RalGDS-RBD was then used to pull down activated Rap1. Cells in 10-cm dishes were incubated in serum-free medium in the absence or presence of EGF or FGF, washed once with ice-cold Ca 2+ -and Mg 2+ -free PBS and lysed in 0.8 ml of Ral buffer. After centrifugation at 13,000 rpm for 10 min at 4 ° C, the supernatant containing about 1.5 mg of total proteins was immediately incubated with glutathione-Sepharose beads (200 l of 50% slurry containing about 80 g of GSTRalGDS-RBD) for 2 h at 4 ° C. Samples were washed three times with Ral buffer, proteins were separated by 12% SDS-PAGE, and activated Rap1 was detected by immunoblot analysis with anti-HA antibodies as described above.
Analysis of MAPK Phosphorylation
To assess phosphorylation of MAPK, cells in 6-cm dishes were incubated in serum-free medium in the absence or presence of EGF or FGF and lysed in 0.6 ml of buffer containing 50 m M TrisHCl, pH 7.5, 100 m M NaCl, 5 m M EDTA, 1% Triton X-100, 1 m M DTT, 200 M Na 3 VO 4 , 40 m M Na 4 P 2 O 7 , 1 m M PMSF and 10 g/ml chymostatin, leupeptin, antipain and pepstatin. Lysates were cleared by centrifugation at 13,000 rpm for 15 min at 4 ° C, and 50 g of proteins were separated by 10% SDS-PAGE and transferred to nitrocellulose filters. Filters were kept for 2 h in BSA blocking solution (50 m M Tris-HCl, pH 7.4, 150 m M NaCl, 0.02% sodium azide, and 5% BSA) and incubated in the same solution with anti-phospho-MAPK antibodies (1: 2,000) for 2 h at room temperature. Immunoreactive bands were visualized by enhanced chemiluminescence. In a set of experiments, transfected HA-p44 MAPK was immunoprecipitated from cell lysates by incubation with 2 g of HA-antibodies for 2 h at 4 ° C. Immune complexes were collected with protein A-Sepharose (50 l of 50% slurry) for 1 h at 4 ° C, centrifuged, and washed three times in lysis buffer. Two equal parts of each immunoprecipitate were then separated by 10% SDS-PAGE and transferred to nitrocellulose filters. Filters were probed with anti-phospho-MAPK antibodies or anti-HA antibodies as described above.
Immunocytochemistry and Confocal Laser Microscopy
For immunocytochemistry studies, CHO cells on polyornithine-coated glass coverslips were washed with PBS, fixed for 1 h with 4% paraformaldehyde and quenched with 100 m M glycine in 120 m M phosphate buffer. After 1 h at 4 ° C in 120 m M phosphate buffer containing 1% BSA and 0.4% saponin, coverslips were incubated for 3 h at room temperature in the same solution containing primary antibodies (1: 200) and extensively washed. Subsequently, coverslips were incubated for 2 h with FITC-, Texas Red-or Cy5-conjugated fluorescent antibodies (Jackson Immuno-Research, West Grove, Pa., USA), extensively washed and mounted on glass slides with FluorSave Reagent (Calbiochem, Darmstadt, Germany). Samples were observed on a Zeiss Axioskop microscope equipped with a confocal head (LSM 510). Confocal images were scanned using a Plan-Apochromat 63 ! /1.40 DIC objective. Excitation was obtained by Argon/2 (488 nm), helium-neon1 (543 nm) and helium-neon2 (633 nm) lasers. Signals were generated and collected individually on a frame-by-frame basis at 2,048 ! 2,048 resolution. Similar pinhole sizes and amplifier settings were used to obtain double labeling images, and no further manipulation of image files was performed. Laser intensities and amplification settings for each individual channel were selected such that autofluorescence seen with control cells was minimized. Images were exported as JPG files and assembled in panels by Adobe Photoshop.
Results
Activated G ␣ o Inhibits EGF Receptor-Dependent Rap1 Activation
Rap1 regulation was investigated in CHO cells transiently transfected with wild-type or mutationally activated G ␣ o , the EGF receptor and HA-Rap1. As shown in figure 1 A, cell exposure to EGF caused a marked accumulation of activated HA-Rap1, with a maximal response at 2 min after the addition of the growth factor. EGF-dependent HA-Rap1 activation was not significantly modified by expression of wild-type G ␣ o , but was virtually abolished in the presence of G ␣ o -Q205L ( fig. 1 B) . Expression of either wild-type or activated G ␣ o did not produce detectable changes in the levels of activated HARap1 in unstimulated cells ( fig. 1 B) . Immunoblot analysis with specific antibodies revealed that these results could not be accounted for by variable levels of expression of HA-Rap1 or G ␣ o in cells transfected with different cDNA combinations.
We verified the subcellular localization of transfected Rap1 and G ␣ o by immunocytochemical analysis. Figure 2 A shows the pattern of staining obtained with anti-HA antibodies in cells expressing wild-type HA-Rap1, where a clear signal was detected in the perinuclear region as well as on the plasma membrane. As shown in figure 2 B, cells transfected with the mutationally activated mutant Rap1-G12V gave comparable results. A similar distribution of endogenous Rap1 has been previously described [19] . Unfortunately, staining with commercially available anti-Rap1 antibodies was not sensitive enough to detect endogenous Rap1 in CHO cells (data not shown). As expected, both wild-type and mutationally activated G ␣ o were found localized at the plasma membrane ( fig. 2 C, D) . G ␣ o -transfected cells also displayed labeling of cytoplasmic vesicular structures most abundant in the perinuclear region. As the anti-G ␣ o antibod-183 ies used in our studies failed to detect the relatively low levels of endogenous protein present in untransfected CHO cells, we do not know whether the same structures also contain the endogenous G ␣ o subunit. This possibility would be consistent with previous reports that showed association of endogenous G proteins with various intracellular membranes [20, 21] . Analysis of cells cotransfected with G ␣ o and HA-Rap1 revealed colocalization of the two proteins at the level of both the plasma membrane and the cytoplasmic vesicles ( fig. 2 E, F) .
Expression of Activated Rap1 Inhibits MAPK Stimulation by EGF
To clarify the role of Rap1 inhibition in the stimulatory effect of G ␣ o on the MAPK cascade, we examined whether Rap1 can somehow regulate MAPK in CHO cells. For these experiments, cells were transfected with the EGF receptor, HA-p44 MAPK and wild-type or mutationally activated Rap1. Immunoblot analysis of cell lysates or anti-HA immunoprecipitates with anti-phospho-MAPK antibodies revealed that wild-type and, to a much greater extent, activated Rap1 inhibited the stimulation of HA-p44 MAPK induced by EGF ( fig. 3 ) . In cell lysates, inhibition of the response of endogenous p42 and p44 MAPK could also be detected. No significant changes in MAPK activation in the presence of either wild-type or activated Rap1 were observed in unstimulated cells. In all these experiments, we noticed that the levels of expression of Rap1-G12V were considerably lower than those observed after transfection of the wild-type protein ( fig. 3 A) . the stimulation of MAPK induced by endogenous FGF receptors [5] . We therefore investigated the effect of activated G ␣ o on Rap1 in cells stimulated with FGF. As shown in figure 4 A, FGF induced a marked activation of HA-Rap1 with a maximal response at 5 min. The stimulatory effect of the growth factor on HA-Rap1 was blocked by expression of G ␣ o -Q205L ( fig. 4 B) . The fact that inhibition of FGF-dependent Rap1 activation by G ␣ o does not result in an amplified MAPK response could be explained by a different sensitivity to Rap1 of the intracellular pathways linking EGF and FGF receptors to MAPK. However, expression of activated Rap1 proved to be able to efficiently inhibit FGF-induced HAp44 MAPK activation ( fig. 4 C) . A similar, but weaker, effect was detected in the presence of wild-type Rap1. In contrast to the results obtained in cells cotransfected with EGF receptors, we did not observe a significant inhibition of FGF activation of endogenous p42 and p44 MAPK by Rap1. This is most likely explained by the fact that endogenous FGF receptors stimulate p42 and p44 MAPK in the entire cell population whereas Rap1 inhibition occurs only in the relatively limited fraction of transfected cells [5] . The effect of G ␣ o on the FGF response suggests that the activation of endogenous Rap1 which is induced by growth factors does not significantly regulate MAPK in CHO cells. To confirm this conclusion, we examined MAPK activation by EGF and FGF in cells expressing HA-Rap1GAPII. As shown in figure 5 A, immunocytochemical analysis of HA-Rap1GAPII distribution revealed a diffuse cytosolic staining [9] . Some labeling of the plasma membrane was also observed. In the presence of Rap1GAPII, activated HA-Rap1 was undetectable under basal conditions and failed to accumulate upon stimulation with EGF or FGF ( fig. 5 B, and data not shown). As previously reported in cells transfected with the GAP protein Rap1GAP [22] , Rap1GAPII also caused a significant decrease in the levels of expression of HA-Rap1. FigFig. 2 185 ure 5 C shows HA-p44 MAPK activation by EGF and FGF in the absence or presence of Rap1GAPII. In control cells, activation of HA-p44 MAPK by EGF was already clearly detectable at 2 min, further increased at 5 min and was considerably reduced at 15 min. The effect of FGF on HA-p44MAPK was rather weak at 2 min, markedly increased at 5 min and declined at 15 min. Expression of Rap1GAPII did not significantly modify the basal levels of HA-p44 MAPK activation and the magnitude and time course of the responses induced by EGF and FGF. Consistently, no significant effect of Rap1GAPII on endogenous p42 and p44 MAPK was observed in these experiments. It should be noted that immunoblot analysis revealed multiple bands corresponding to HARap1GAPII and that a change in the relative intensities of these bands was reproducibly observed after stimulation with either EGF or FGF. It is conceivable that these observations reflect modifications of the phosphorylation state of Rap1GAPII induced by the growth factors [23] . Taken together, these results indicate that the stimulatory effect of G ␣ o on the MAPK cascade observed in CHO cells is not explained by its ability to inhibit Rap1 activation.
Discussion
Various G-protein ␣ subunits appear able to control the function of small G proteins [2, 3, [8] [9] [10] 24] . The results reported here demonstrate that activated G ␣ o can negatively regulate the Rap1 pathway in CHO cells. This conclusion is consistent with a previous report which showed inhibition of Rap1 activation by G ␣ o -Q205L in PC12 cells [8] . In both PC12 and Neuro-2A cells, expression of wild-type G ␣ o has been previously found to increase the basal levels of activated Rap1 [8, 10] . This effect has been explained by the ability of the wild-type subunit to sequester Rap1GAPII away from Rap1 and to promote proteasomal degradation of the GAP protein. Based on the response to prolonged stimulation of the cannabinoid receptors in Neuro-2A cells, it has been proposed that also the active form of G ␣ o , which interacts weakly with Rap1GAPII, causes Rap1 activation by enhancing the degradation of Rap1GAPII [10] . In our experiments, we could not detect any stimulatory effect of G ␣ o on the levels of activated Rap1. However, we found that wild-type and, to a limited extent, activated G ␣ o decrease the expression of transfected Rap1GAPII (unpubl. observations). These contradictory results could be explained by differences in the expression of Rap1 and Rap1GAPII or in the regulation of Rap1 by GAP proteins in the different cell systems investigated. Regardless of the actual mechanism(s) involved, our study suggests that in certain cell types the G ␣ o subunit exclusively exerts an inhibitory effect on Rap1 function. Clearly, further work is needed to elucidate the regulation of the Rap1 pathway by G ␣ o .
The subcellular localization of Rap1 has recently raised considerable interest. Rap1 is detected at high levels on cytoplasmic vesicles particularly abundant in the perinuclear region of the cell, which have been identified as endosomes or maturing phagosomes [19, 25] . The plasma membrane of different cell types seems also to be enriched in Rap1 [19, 26] . Some uncertainty about the sub- cellular site of activation of Rap1 by growth factors still remains, with reports suggesting that this event takes place in the perinuclear region [27] or at the plasma membrane [19] . Consistently with the latter possibility, it has been shown that the ␣ chain of G z inhibits NGF-dependent Rap1 activation by translocating Rap1GAPII from the cytosol to the plasma membrane [28] . In our experiments, transfected Rap1 and G ␣ o were found to be present and to colocalize both at the plasma membrane and on cytoplasmic vesicles, suggesting that both scenarios are theoretically possible in CHO cells.
Two lines of evidence demonstrate that inhibition of Rap1 activation does not account for the ability of G ␣ o to regulate MAPK in CHO cells: (1) G ␣ o -Q205L inhibits Rap1 activation by both EGF and FGF but only poten tiates the MAPK response induced by EGF, and (2) Rap1GAPII expression does not significantly modify growth factor-dependent activation of MAPK. Previous results have shown that G ␣ o -dependent MAPK stimulation requires the B-Raf kinase and both PKC and PI3K [5, 6] . The molecular mechanisms involved in the pathway initiated by G ␣ o remain to be further elucidated. The data reported here also imply that, in CHO cells, Rap1 does not play an important role in the stimulation of the MAPK cascade induced by growth factor receptors. A lack of correlation between Rap1 function and MAPK activation has been previously observed [12, 16, 17, 22] . In our experiments, there is a clear discrepancy between the effects of activated Rap1 and the results obtained in cells expressing Rap1GAPII. The simplest explanation of this discrepancy is that the response to activated Rap1 is due to expression of the protein at high levels and/or for prolonged periods of time. Alternatively, Rap1 activation by receptors might take place only at a specific subcellular location while transfection of Rap1 is followed by a diffuse action within the cell.
There is evidence that Rap1 inhibition mediates stimulation of MAPK by G ␣ i during activation of the M 2 receptor in 293T cells [9] . Obviously, such a mechanism can only operate in cells in which Rap1 negatively regulates the MAPK pathway. It is therefore possible to imagine that in some systems, such as CHO cells, G ␣ o activates MAPK independently of Rap1 while in other specific cell types it uses Rap1 inactivation to stimulate the MAPK cascade. It should also be mentioned that the ability of Rap1 to activate MAPK in neurons and other cell types [13] [14] [15] implies that G ␣ o , by inducing Rap1 inactivation, can exert a negative rather than a positive effect on MAPK activity. Indeed, it has been shown that activated G ␣ o blocks MAPK activation by NGF receptors in PC12 cells and is involved in MAPK inhibition by the dopamine D 2 receptor in pituitary cells [8, 29] .
Regulation of Rap1GAPII and Rap1 can mediate some of the effects of the G ␣ o subunit on the MAPK cascade. Recent studies have also shown that a Rap1-dependent pathway is involved in stimulation of neurite outgrowth by G ␣ o in Neuro-2A cells [10] . Continuously increasing evidence indicates that Rap1 plays an important role in the control of many cell functions including synaptic transmission and plasticity, adhesion, motility and phagocytosis [12, 13, [30] [31] [32] . It will be of considerable interest to investigate the effects of G ␣ o on the various responses controlled by Rap1. These studies will clarify the role of Rap1 regulation by G ␣ o in CHO cells and, most conceivably, other cell types in which the Rap1 and MAPK responses to this G-protein subunit are independent processes.
